Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study.
Saved in:
| Title: | Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study. |
|---|---|
| Authors: | Bouthillier A; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Bastien G; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., McAnulty C; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Bakouni H; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, ON, Canada., Socias ME; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Jutras-Aswad D; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca. |
| Source: | Harm reduction journal [Harm Reduct J] 2025 Feb 08; Vol. 22 (1), pp. 14. Date of Electronic Publication: 2025 Feb 08. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Pragmatic Clinical Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39923043 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bouthillier+A%22">Bouthillier A</searchLink>; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Bastien+G%22">Bastien G</searchLink>; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22McAnulty+C%22">McAnulty C</searchLink>; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Bakouni+H%22">Bakouni H</searchLink>; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Le+Foll+B%22">Le Foll B</searchLink>; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Socias+ME%22">Socias ME</searchLink>; British Columbia Centre on Substance Use, Vancouver, BC, Canada.; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Jutras-Aswad+D%22">Jutras-Aswad D</searchLink>; Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada. didier.jutras-aswad@umontreal.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101153624%22">Harm reduction journal</searchLink> [Harm Reduct J] 2025 Feb 08; Vol. 22 (1), pp. 14. <i>Date of Electronic Publication: </i>2025 Feb 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Pragmatic Clinical Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101153624 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-7517 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214777517%22">14777517 </searchLink><i>NLM ISO Abbreviation: </i>Harm Reduct J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39923043 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12954-025-01157-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 14 Titles: – TitleFull: Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bouthillier A – PersonEntity: Name: NameFull: Bastien G – PersonEntity: Name: NameFull: McAnulty C – PersonEntity: Name: NameFull: Bakouni H – PersonEntity: Name: NameFull: Le Foll B – PersonEntity: Name: NameFull: Socias ME – PersonEntity: Name: NameFull: Jutras-Aswad D IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 02 Text: 2025 Feb 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1477-7517 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: Harm reduction journal Type: main |
| ResultId | 1 |
